biostudies-literatureUnknown15Forschner JFrontiers in oncologyhttps://www.ebi.ac.uk/biostudies/studies/S-EPMC12378509biostudies-literatureAdjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutationPMC12378509Flatz LEigentler TGarbe CForschner ABonzheim IAmaral THuynh JSeibel-Kelemen OReitmajer MForschner JOssowski SArmeanu-Ebinger SSchroeder CGschwind AfalseAdjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation2025-01-01T00:00:00Z2025 Jan2026-05-10T04:21:36.108Z2026-04-08T01:28:49.624ZS-EPMC12378509